MARÍA PILAR
GARCÍA ALFONSO

Profesora asociada de Ciencias de la Salud

Foto de MARÍA PILAR

Foto de Carmen

Carmen
Guillén Ponce

Carmen Guillén Ponce-rekin lankidetzan egindako argitalpenak (6)

2022

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study
Cancers, Vol. 14, Núm. 24

2021

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231

2019

Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: Retrospective analyses of two phase II randomised Spanish TTD trials
ESMO Open, Vol. 4, Núm. 6

2018

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
European Journal of Cancer, Vol. 101, pp. 263-272

2016

Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?
Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1072-1081

2014

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer
Clinical and Translational Oncology, Vol. 16, Núm. 11, pp. 942-953